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1. Introduction 
Despite recent trends indicating that new diagnoses of breast cancer have decreased slightly, 
the American Cancer Society estimates that there will be 207,090 new cases of invasive 
breast cancer and 54,010 new cases of in situ (i.e., early stage) breast cancer that are likely to 
have developed in 2010 (American Cancer Society, 2010). Given that the 5-year survival rate 
for breast cancer is now 90% and that the National Cancer Institute estimates that there were 
approximately 2.5 million women living in 2006 who had a history of breast cancer 
(American Cancer Society, 2010; Horner et al., 2009), experiencing breast cancer is 
increasingly about survivorship. Breast cancer survivors are at lifetime risk for developing 
lymphedema, a chronic condition that occurs in up to 40% of this population (Armer, 
Stewart, & Shook, 2009; American Cancer Society, 2007; Ferlay, Bray, Pisani, & Parkin, 2004). 
Lymphedema involves the accumulation of protein-rich fluid that impacts physical, 
functional, and psychosocial health and well-being. Second only to breast cancer recurrence, 
lymphedema is the most dreaded outcome of breast cancer treatment. Research has shown 
that women with breast cancer-related lymphedema report their most frequent action for 
management of lymphedema symptoms is no action (Armer & Whitman, 2002). This 
indicates that patient education about self-care is critical for effective self-management and 
risk reduction. Given the distressing and chronic nature of breast cancer-related 
lymphedema, there are both individual and family level psychosocial impacts related to the 
onset and long-term management.  
This chapter is aimed at addressing real and present concerns for both patients and their 
family members regarding breast cancer-related lymphedema. All too often these 
individuals are poorly prepared to cope with the potential or actual realities of living with 
this physically limiting chronic condition. At the same time, many patients and family 
members report being both unaware that lymphedema was a possible outcome of breast 
cancer treatment and that medical staff, in particular oncologist and surgeons, are not well 
informed and/or not helpful in guiding them on how to cope. What is offered in this 
chapter is an overview of the condition with special attention paid to informing readers 
(e.g., physicians, nursing, social workers, family therapists, and others who work with 
patients and their families) so that they might be better equipped to serve patients and the 
family members. Thus, the focus of this chapter is thus two-fold: 1) patient (and family 
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member/ caregiver) education regarding strategies for early detection, risk reduction, and 
management/self-care and 2) individual and family level psychosocial impacts of coping 
with breast cancer-related lymphedema.  
2. Defining breast cancer-related lymphedema 
Breast cancer-related lymphedema, a syndrome of abnormal swelling and multiple 
distressing symptoms, is a major adverse effect of breast cancer treatment (Fu & Rosedale, 
2009). Lymphedema is a chronic condition involving accumulation of protein-rich fluid that 
impacts physical, functional, and psychosocial health and well-being (Beaulac, McNair, 
Scott, LaMorte, & Kavanah, 2002; Geller, Vacek, O'Brien, & Secker-Walker, 2003; Hull, 1998; 
Radina & Armer, 2004; Voogd et al., 2003). (Figure 1). 
  
 copyright by Mei R. Fu. All rights reserved. 
Fig. 1. Example of Breast Cancer-related Lymphedema. 
While the exact cause of breast cancer-related lymphedema is unknown, evidence 
suggests that some cancer treatments may increase the risk of developing breast cancer-
related lymphedema; risks that include the surgical removal of lymphatic vessels and 
nodes and the development of tissue fibrosis that sometimes follow radiation treatments, 
infection, or surgery (Kwan et al., 2002). Common breast cancer treatments damage and 
potentially weaken the lymph nodes and the vessels carrying lymph fluid, which may 
then compromise the effectiveness of the valves in the lymph vessels (Smith, 1998). The 
result is the accumulation of lymph fluid in the tissues of the arm, hand, chest, back, and 
neck (Berne & Levy, 1996). Changes in physical appearance and limitations created by 
lymphedema can affect physical and psychological health as well as interpersonal 
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relationships (Casley-Smith, 1992; Passik & McDonald, 1998; Passik, Newman, Brennan, & 
Tunkel, 1995; Radina, Watson, & Faubert, 2009; Thomas-MacLean, Miedema, & Tatemichi, 
2005). Although women with breast cancer-related lymphedema report a variety of 
physical symptoms (e.g., pain, heaviness, tenderness, numbness, limited range of motion, 
and stiffness), arm swelling is the most common (Armer, Radina, Porock, & Culbertson, 
2003; Coster, Polle, & Fallowfield, 2001; Thomas-MacLean et al., 2005). In addition, those 
coping with this chronic, sometimes disabling, condition are subject to frustrating 
physical limitations (e.g., being unable to lift heavy objects; reducing activities that 
require repetitive motions with the arm; keeping the arm elevated) (Radina & Armer, 
2001; Ridner, 2002).  
3. Diagnosis of breast cancer-related lymphedema 
Early diagnosis of breast cancer-related lymphedema remains a clinical challenge. 
Traditionally, lymphedema has been clinically diagnosed by healthcare professionals’ 
observations of swelling, and has often arbitrarily been defined in research as a 2-cm 
increase in limb girth, a 200-mL or more increase in limb volume, or a 5% or greater limb 
volume change (Armer et al., 2004; Cormier et al., 2009; Stout et al., 2008). Inconsistency in 
the criteria defining lymphedema and the use of different measures has posed 
tremendous difficulty in accurately diagnosing lymphedema (Armer & Stewart, 2005). 
Additional contributing factors to the challenge include failure to precisely evaluate 
symptoms related to lymphedema, co-existing conditions, insufficient knowledge and 
lack of awareness among healthcare professionals. Several diagnostic approaches have 
been used for diagnosing breast cancer-related lymphedema, including the patient’s 
health history and physical examination, measures of limb volume, and lymph vessle 
imaging.  
3.1 Health history and physical examination 
Early and accurate diagnosis of breast cancer-related lymphedema is essential to prevent 
complications and achieve optimal management. A careful review of the patient's health 
history can promote accurate diagnosis to rule out other medical conditions that may cause 
similar symptoms. Such medical conditions include recurrent cancer, deep vein thrombosis, 
chronic venous insufficiency, diabetes, hypertension, cardiac and renal disease. These 
alternative diagnoses should be ruled out before establishing a diagnosis of lymphedema 
and referring the patient for lymphedema therapy.  
A four-stage system (Table 1) can be used to facilitate physical examination to classify 
lymphedema in terms of skin condition and swelling (International Society of Lymphedema 
([ISL], 2003). Within each stage, severity of lymphedema based on volume difference can be 
assessed as mild (<20% increase), moderate (20-40% increase), or severe (>40% increase). It 
should be noted that a clinical diagnosis of lymphedema in the current practice patterns is 
very often made when swelling becomes visually evident and is usually classified as “mild” 
lymphedema. Mild lymphedema is often defined as an initially reversible. However, by the 
time lymphedema is visually observable (as described in the Stage 2) it has already evolved 
into the irreversible advanced stages.   
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Stages Presentations 
0 Latent or sub-clinical condition  No noticeable swelling  
 No pitting  
 A feeling of heaviness  
 Existing months or years before overt 
swelling occurs  
i. Early accumulation of lymph fluid  Pitting swelling  
 Visible swelling 
ii. Increased or chronic swelling  Pitting swelling 
 Hardened and thickened tissue  
iii. Lymphostatic elephantiasis  Absence of pitting swelling 
 Enlarged and obvious swelling of the 
affected limb  
 Hardness, thickness, and toughness of 
skin  
 Lymph leaking through damaged skin  
Table 1. Staging of Lymphedema (International Society of Lymphedema ([ISL], 2003) 
Symptom assessment is essential since very often observable swelling and measurable 
volume changes are absent during the initial development of lymphedema, but patients 
may report such symptoms as heaviness, tightness, firmness, pain, or numbness (Cormier et 
al., 2009; Fu & Rosedale, 2009). These symptoms may be the earliest indicator of increasing 
interstitial pressure changes associated with lymphedema (Kosir et al., 2001). As the fluid 
increases, the limb may become visibly swollen with an observable increase in limb size. 
Recent research shows that limb volume change (LVC) by the infra-red perometer has 
significantly increased as breast cancer survivors’ reports of swelling, heaviness, tenderness, 
firmness, tightness, and aching have increased (Cormier et al., 2009). On average, breast 
cancer survivors reported 4.2 symptoms for survivors with <5.0% LVC; 5.5 symptoms for 
5.0-9.9% LVC, 7.0 symptoms for 10.0-14.9% LVC, and 12.5 symptoms for > 15% LVC, 
respectively (p<0.001) (Cormier et al., 2009). Because early intervention is believed to yield 
better patient outcomes, the presence of lymphedema symptoms should warrant institution 
of early interventions (Armer, Radina, Porock, & Culbertson, 2003; Armer et al., 2004; Foeldi 
et al., 2003). In addition, experience of symptoms has elicited tremendous distress in breast 
cancer survivors and exerted negative impact on their quality of lives (Fu & Rosedale 2009; 
Pyszel et al., 2006). Symptoms should be one of the major patient-centered clinical outcomes 
for evaluating the effectiveness of lymphedema treatment (Armer et al., 2005; Sitzia, 
Stanton, & Badger, 1997). A symptom checklist (Table 2) may be used for symptom 
assessment. 
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The following questions are about symptoms in your affected arm, hand, breast, axilla 
(under arm), or chest today or in the past three months. 
 How Severe? 
Have you had ___? 
No 
0 
A little 
1 
Somewhat 
2 
Quite a bit 
3 
Very Severe 
4 
1. Shoulder       
2. Elbow      
3. Wrist       
4. Fingers       
5. Arm      
6. Hand or arm swelling        
7. Breast swelling      
8. Chest wall swelling      
9. Firmness       
10. Tightness      
11. Heaviness      
12. Toughness or thickness of skin      
13. Stiffness       
14. Tenderness      
15. Hotness/increased temperature      
16. Redness      
17. Blistering      
18. Pain/aching/soreness      
19. Numbness       
20. Burning       
21. Stabbing       
22. Tingling (pins and needles)      
23. Arm or hand fatigue      
24. Arm or hand weakness      
Copyright 2006-2009  College of Nursing, New York University. Contact Mei R. Fu, PhD, RN, ACNS-
BC; Telephone: 212-998-5314;  Email: mf67@nyu.edu 
Table 2. Example of Symptom Checklist - Breast Cancer & Lymphedema Symptom 
Experience Index 
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Physical examination and symptom assessment can also help to differentiate if the onset of 
lymphedema following breast cancer treatment is gradual or sudden (Fu et al., 2009). It is 
still not fully understood why some patients are more prone to fluid build-up than others 
even with similarity in surgical treatment, numbers of lymph nodes removed, 
chemotherapy and radiotherapy. With gradual onset, noticeable swelling is often absent 
initially, but patients may report feelings of tightness and heaviness in the previous year, 
visible and measurable lymphedema typically occurs two to five years after treatment, but it 
can also happen as many as 15 to 30 years later (Armer et al., 2003; Petrek, Senie, Peters, & 
Rosen, 2001). With sudden onset, swelling develops rapidly, usually within 24 hours and 
often breast cancer survivors are able to identify the triggers, such as air travel, infection, or 
injuries (e.g., cuts, insect bites, pinpricks, burns) (Fu & Rosedale, 2009; Johansson, et al., 
2002; Petrek et al., 2001). With infection (especially cellulitis) or injuries, breast cancer 
survivors usually experience sudden swelling with redness, elevated white blood cells, or 
elevated temperature (Foeldi et al., 2003). Very often, immediate administration of oral or IV 
antibiotics can clear the infection, while elevation of the limb helps to reduce the swelling. It 
is possible that early stage lymphedema (Stage 1 and 2) may continue to exist in a latent or 
sub-clinical state even when successfully treated at initial onset, sometimes presenting at 
later stages ten or more years after initial diagnosis of sudden onset of lymphedema 
(Brennan & Miller, 1998).  
3.2 Measures of limb volume (LV) 
Measuring LV is an objective way to quantifying lymphedema. However, quantifying 
lymphedema is a challenge because various measurement approaches have been used to define 
lymphedema and certain types of breast cancer-related lymphedema such as breast, shoulder, 
and truncal lymphedema cannot be quantified with current measurement technology.  Methods 
of measuring limb volume LV include sequential circumference limb measurement, water 
displacement, infra-red perometry, and bioimpedance spectroscopy (Armer & Stewart, 2005; 
Petlund, 1991; Tierney, Aslam, Rennie, & Grace, 1996; Cornish, et al., 2001).  
3.2.1 Sequential circumferential arm measurements 
Measuring circumference is the most widely used diagnostic method. A flexible non-stretch 
tape measure for circumferences is usually used to assure consistent tension over soft tissue, 
muscle, and bony prominences (Armer et al., 2004; Petlund, 1991). Measurements are done 
on both affected and non-affected limbs at the hand proximal to the metacarpals, wrist, and 
then every 4 cm from the wrist to axilla or at minimum, six measurements are 
recommended: circumference at the mid‐hand, wrist, elbow, upper arm just below the 
axilla, and at 10cm distal to and proximal to the lateral epicondyle on both arms (Armer et 
al., 2004; Callaway et al., 1988) The most common criterion for diagnosis has been a finding 
of ≥ 2 cm or >200 ml difference in limb volume as compared to the non-affected limb or 10% 
volume differences in the affected limb (Armer et al., 2004; Armer & Stewart, 2005; 
Mayrovitz, Simms, & MacDonald, 2000; Stanton et al., 2009).  
Circumferential limb measurement has limited inter- and intra-rater reliability and costly in 
terms of training time and clinician’s time for measurement (Armer & Stewart, 2005; Gerber, 
1998). (Figure 2). 
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 copyright by Jane Armer. All rights reserved. 
Fig. 2. Sequential Circumferential Arm Measurements 
3.2.2 Water displacement 
Water displacement is seldom used in clinical settings because of cumbersome spillover and 
hygienic concerns (Armer & Stewart, 2005; Gerber, 1998). Patients submerge the affected 
arm in a container filled with water and the overflow of water is caught in another container 
and weighed (Figure 3). This method does not provide data about localization of swelling or 
shape of the extremity (Petlund, 1991; Tierney et al., 1996). The method is contraindicated in 
patients with open skin lesions. Patients may find it difficult to hold the position for the time 
needed for the tank overflow to drain.  
 
 copyright by Jane Armer. All rights reserved. 
Fig. 3. Water Displacement 
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3.2.3 Infra-red perometry 
The advent of infra-red perometry (also called optoelectronic volumetry), such as the 
perometer 350S (Juzo, Cuyahoga Falls, OH), enables reliable and accurate detection of 3% 
limb volume change (LVC) (Cormier et al., 2009; Stout et al., 2008). The perometer works in 
much the same manner as computed tomography but uses infrared light instead of X-rays 
(Petlund, 1991). There is no toxic effect to the patient. Perometry is performed on each arm 
as it is held horizontally with the patient standing comfortably (Figure 4). The perometer 
maps a 3-dimensional graph of the affected and non-affected extremities using numerous 
rectilinear light beams, and interfaces with a computer for data analysis and storage. A 3-
dimensional limb image is generated and LV is calculated. This optoelectronic method has a 
standard deviation of 8.9 ml (arm), less than 0.5% of LV with repeated measuring (Armer & 
Stewart, 2005; Cormier et al., 2009). Because the perometer is capable of measuring bilateral 
lymphedema and localization of swelling as well as detecting a 3% LVC that enables 
detectable differences in quality of life (QOL) and symptom reporting,  the optimal measure 
for lymphedema is the evaluation of LVC by the perometer (Armer & Stewart, 2005; 
Cormier et al., 2009; Stout et al., 2008).  
 
 copyright by Mei R. Fu. All rights reserved. 
Fig. 4. Infra-red Perometry 
3.2.4 Bioimpedance spectroscopy (BIS) 
Bioelectrical impedance has been used to detect onset lymphedema and monitor results of 
lymphatic massage in clinical settings (Cornish, et al., 2001; Ridner, Montgomery, 
Hepworth, Stewart, & Armer, 2007; Ward, Bunce, Cornish, Mirolo, Thomas, & Jones, 1992; 
Ward, Essex, & Cornish, 2006). The Imp XCA® (Impedimed, Brisbane, Australia) uses a 
single frequency below 30 kHz to measure impedance and resistance of the extracellular 
fluid. The device uses the impedance ratio values between the unaffected and affected limb 
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to determine arm lymphedema. Ratio means of 1.139 for at-risk dominant arms and 1.066 
for at-risk non-dominant arms are indicators of arm lymphedema. The Imp XCA® uses the 
impedance ratio values to calculate a Lymphedema Index [L-Dex]. The L-Dex scale ranges 
from -10 to +10, which is equivalent to the impedance ratio from 0.935 to 1.139 for at-risk 
dominant arms and 0.862 to 1.066 for at-risk non-dominant arms, respectively. Each one 
standard unit in L-Dex is equivalent to the impedance ratio of 0.03. A patient is determined 
to have arm lymphedema or arm swelling if the patient’s L-Dex exceeds the normal value of 
+10, i.e. exceed impedance ratio means of 1.139 for at-risk dominant arms and 1.066 for at-
risk non-dominant arms, respectively (44). Measurement of arms takes less than five 
minutes when using the Imp-XCA® and results are immediately available to clinicians. 
However, the Imp XCA® is only capable of assessing unilateral lymphedema, unable to 
provide data about localization of swelling or shape of the extremity, and cannot be applied 
to patients with renal or heart failure, cardiac pacemaker or defibrillator, inability to lying 
down on the exam table, artificial limbs, or pregnancy as accurate measurement of 
lymphedema may not be possible. Continuous cost for electrodes is needed. (Figure 4). 
 
 copyright by Mei R. Fu. All rights reserved. 
Fig. 5. Bioimpedance Spectroscopy (BIS). 
3.3 Lymph vessel imaging  
Lymphoscintigraphy (isotope lymphography) can ensure definite lymphedema diagnosis 
(Mortimer, 2003; Cambria et al., 1993). Lymphoscintigraphy employs a nuclear medicine to 
visualize the lymph vessel. With the patient supine, a radiolabelled macromolecular tracer 
(Tc-99m filtered [0.22 milli micron] or unfiltered sulfur colloid) is injected intradermally 
within one of the interdigital spaces of the affected limb using a 25-gauge needle in a 1 ml 
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syringe (Cambria et al., 1993; Partsch, 1995; Ter et al., 1993). The injection is given between 
the index and middle finger in the web space for the upper limbs. Both sides are done 
simultaneously so that the affected limb can be compared to the unaffected limb. The 
lymphatic transport of the macromolecule is tracked with a gamma camera, and the rate of 
tracer disappearance from the injection site and the accumulation of counts within the 
lymph node are both quantified. Typical abnormalities observed in lymphedema include 
dermal backflow, absent or delayed transport of tracer, cross-over filling with retrograde 
backflow, and either absent or delayed visualization of the lymph nodes (Cambria et al., 
1993; Partsch, 1995; Ter et al., 1993). However, lymphography is now rarely used in patients 
because of its potential to cause lymphatic injury and its inability to clarify function (Meek, 
1998; Mortimer, 2003).  
4. Treatment of breast cancer-related lymphedema 
Treatment of lymphedema has been and continues to be a major healthcare challenge since 
no treatment can cure this chronic condition. Lymphedema treatment refers to therapies 
applied to help to slow the disease progression by reducing or maintaining swelling and 
relieving symptoms. Lymphedema therapy includes complete decongestive physiotherapy, 
pneumatic compression therapy (PCT), therapeutic exercises, surgery, and pharmacological 
therapy (Fu, 2005; Geller, Vacek, O’Brien, & Secker-Walker, 2003; ISL, 2003; Megens & 
Harris, 1998).  
4.1 Complete decongestive therapy (CDT) 
Complete decongestive therapy (also known as complex decompressive physiotherapy, 
comprehensive decongestive treatment, and multimodal physical therapy) is the standard of care 
for breast cancer-related lymphedema. CDT includes an initial reductive treatment phase 
followed by an ongoing maintenance phase. The reductive treatment phase involves 2-5 
sessions per week for 3 to 8 weeks in a specialized lymphedema clinic until the reduction 
of fluid volume has reached a plateau. The reductive treatment phase of CDT consists of 
multiple components, including manual lymph drainage (MLD), multilayer, short-stretch 
compression bandaging, therapeutic exercise, skin care, education in self-management, 
and elastic compression garments (Davis, 1998; Megens & Harris, 1998). The reductive 
treatment phase should be reinstituted whenever swelling is exacerbated or whenever 
symptoms are worsened. Once the reductive treatment phase is completed, the 
maintenance phase starts in which the patient continues self-management with skin care 
and exercise, self MLD, and use of a compressive sleeve and gauntlet during the day and 
arm bandaging at night (Davis, 1998; Megens & Harris, 1998). The maintenance phase of 
CDT requires a lifelong self-management program with self MLD, exercise, skin care, and 
compression garments or bandages. Long-term volume reduction is as high as 50-63% in 
up to 79% of patients who are 100% compliant (Boris et al., 1997; Erickson et al., 2001; 
Foeldi et al., 2003; Rinerhart-Ayres, 1998). Yet, compliance with the prescribed self-
management regimen during the maintenance phase is difficult for breast cancer 
survivors (Brennan & Miller, 1998; Fu, 2010). From the patient’s perspective, the treatment 
for lymphedema itself is a constant reminder that prevents survivors from living a normal 
life (Fu, 2005; Fu & Rosedale, 2009). 
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4.2 Pneumatic compression therapy  
Pneumatic compression therapy, also known as compression pump therapy, can be used 
daily for 30-60 minutes during the maintenance phase of CDT. Acceptable pneumatic 
compression device (PCD) should have multiple chambers delivering a sequential pressure. 
Caution must be used, however, because compression pumps can damage the vasculature. 
Furthermore, compression devices are contraindicated in patients with congestive heart 
failure, active infection, or deep venous thrombosis (Rockson et al., 1998). The recently 
developed PCD such as the Flexitouch® system is believed to be safer than the older PCD 
(Ridner et al., 2010). The Flexitouch® system is an advanced, programmable PCD that is 
cleared by the Food and Drug Administration for home use. This device is the only PCD 
designed to emulate the therapeutic techniques of MLD. Published studies and case reports 
suggest that breast cancer-related limb and truncal lymphedema may be effectively treated 
with the Flexitouch® system since the device includes garments to treat truncal swelling 
(Ridner et al., 2010).  
4.3 Therapeutic exercises 
Therapeutic exercises are individualized remedial exercises that consist of cardiovascular 
exercises, stretching, aerobic activity, and strength training. Therapeutic exercise is believed 
to increase lymph flow and protein absorption through repeated contraction and relaxation 
of muscles. Therapeutic exercise should be initiated by well-trained lymphedema therapists 
and then continued at home. One randomized controlled trial found that a 6-month 
intervention did not increase risk or add to symptoms of lymphedema (Ahmed et al., 2006). 
Other data also indicate that exercise as an individual therapy is neither a contraindication 
after breast cancer treatment nor does it decrease the risk of developing lymphedema 
(Ahmed et al., 2006; Schmitz et al., 2009; Johansson et al., 2005). For survivors with 
lymphedema, compression garments or compression bandages must be worn during 
exercise to counterbalance the buildup of interstitial fluid (Schmitz et al., 2009; Johansson et 
al., 2005).  
4.4 Surgery 
Surgical approaches are performed to debulk tissue or to divert lymphatic drainage (Casley-
Smith, 1992; Cormier et al., 2011). Surgical treatment for breast cancer-related lymphedema 
is rarely performed except in severe and refractory cases to reduce the weight of the 
lymphedematous region, minimize the frequency of infectious and inflammatory episodes, 
and improve cosmesis and function. Surgical treatment includes: (1) excisional operations 
(e.g., debulking, amputation, and liposuction), (2) lymphatic reconstruction, and (3) tissue 
transfer procedures (e.g., lymph node transplantation, pedicled omentum, bone marrow 
stromal cell transplantation) (Cormier et al., 2011). For severe lymphedema, excisional 
operations and debulking procedures have been reported as effective methods to alleviate 
symptoms by removing fibrosclerotic connective tissue, excess adipose tissue, and excess 
skin. Various microsurgical techniques for lymphatic reconstruction have been attempted 
since the early 1960s, including the creation of anastomoses between lymphatic channels 
and adjacent veins, between lymph nodes and veins, and between distal and proximal 
lymphatics (Campisi et al., 2001; O’Brien et al., 1990). Lympho-lymphatic anastomosis and 
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lymphatic grafting have been used as reconstructive techniques that are associated with 
improved patency over time (Brennan & Miller, 1998). A recent systematic review on 
surgical treatment for lymphedema revealed that the largest reported reductions were noted 
after excisional procedures (91.1%), lymphatic reconstruction (54.9%), and tissue transfer 
procedures (47.6%) (Cormier et al., 2011). Potential complications may occur with surgical 
management of lymphedema, such as recurrence of swelling, poor wound healing, and 
infection; thus surgical treatment should  be considered only when other treatments fail, and 
with careful consideration of the benefits-to-risks ratio (Casley-Smith, 1992). It should be 
noted although these surgical approaches have shown promising results, nearly all the 
surgical procedures do not obviate the need for continued use of conventional therapies, 
including compression, for long-term maintenance (Cormier et al., 2011). 
4.5 Pharmacological therapy 
Pharmacological interventions to treat lymphedema include antibiotics for treatment of 
infections, benzopyrones, flavonoids, diuretics, hyaluronidase, pantothenic acid, and 
selenium (Bruns et al., 2003; Rockson et al., 1998; Olszewski et al., 2000). Although not 
approved by the US Food and Drug Administration (FDA), benzopyrones have drawn most 
of the attention as a pharmacologic approach to treat lymphedema (Rockson et al., 1998). 
Benzopyrones are believed to encourage protein breakdown and lead to a subsequent 
decrease in lymph fluid. One randomized controlled trial of benzopyrones and placebo 
showed a significant decrease in arm swelling after treatment for several months (Davis, 
1998). Loprinzi (1999) conducted a controlled study on the effectiveness of coumarin 
compared with a placebo, and they concluded that coumarin was not effective for managing 
breast cancer-related lymphedema due to a high risk of hepatotoxicity.  A Cochrane review 
found that it was not possible to draw conclusions about the effectiveness of benzopyrones 
in reducing and controlling lymphedema due to the poor quality of existing trials (Badger et 
al., 2004). Flavonoids, hyaluronidase, pantothenic acid, and selenium have also 
demonstrated limited efficacy (Olszewski et al., 2000; Bruns et al., 2003). Diuretics are not 
suitable for breast cancer-related lymphedema, as such medications only serve to increase 
protein concentrations in the interstitium and encourage increase in swelling, inflammation 
and fibrosis (Davis, 1998; Thiadens, 1998).  
5. Risk reduction for and early detection of breast cancer-related 
lymphedema 
5.1 Risk reduction 
Breast cancer-related lymphedema is often under-diagnosed and undertreated. The 
complexity and variability of individual lymphatic system and the unpredictability of risk 
factors makes it difficult to predict which patients will ultimately develop lymphedema. For 
decades, to reduce the risk of lymphedema after breast cancer treatment, the focus has been 
on improving surgical treatment. Such improvements, including sentinel lymph node 
biopsy (SLNB) in which one to three sentinel lymph nodes are removed, and breast-
conserving surgery (BCS) in which only the cancerous part of the breast is removed (Armer 
et al., 2004), have saved patients with node-negative disease from unnecessary axillary 
lymph node dissection (ALND) and mastectomy (Boneti et al., 2008; Giuliano et al, 2011). 
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While lymphedema and symptoms have been reported less frequently in women who 
underwent SLNB only, lymphedema has by no means becomes a minor or disappearing 
problem. Data from recent studies have revealed that lymphedema remains a significant 
complication of breast cancer treatment, occurring in 20% to 47% of cases after ALND and in 
3% to 17% after SLNB (Cormier et al., 2009; Paskett et al., 2007; Langer et al., 2007; 
McLaughlin et al., 2008). It is very important to note that surgical removal of lymph nodes 
remains the optimal choice for treating breast cancer with positive cancerous lymph nodes 
(Boneti et al., 2008; Giuliano et al, 2011, Langer et al., 2007). Each year in the US, more than 
190,000 women are diagnosed with invasive breast cancer and many of them undergo 
removal of positive lymph nodes despite the use of SLNB, predisposing the women to a life-
time risk for lymphedema.  
In addition, radiation exposure is associated with trauma to the lymphatic system, and 
current standard of care includes BCS and SLNB together with radiation therapy to breast 
and /or axilla. Recent innovative approaches to radiotherapy include the single-day 
targeted intraoperative radiotherapy delivered by the Targit machine (Enderling, 
Anderson, Chaplain, Munro, & Vaidya, 2006; Vaidya et al., 2006) and the 5-day 
accelerated partial breast irradiation using a MammoSite catheter (Benitez, et al. 2006; 
Berlin, Gjores, Ivarsson, Palmqvist, Thagg, & Thulesius, 1999; Borg et al., 2007; Dragun, 
Harper, Jenrette, Sinha, & Cole, 2007; Jeruss et al., 2006). Such novel radiotherapies 
targeting directly on the tumor site while avoiding scattering radiation to the axilla may 
have a role in reducing the risk of lymphedema in comparison to conventional 
radiotherapy. Research is needed to evaluate targeted radiotherapies in relation to 
lymphedema risk reduction. As a result, current surgical approaches for diagnosis of and 
treatment for breast cancer continue to make patients susceptible to the risk of 
lymphedema.  
Besides unavoidable risk factors, such as breast surgery (mastectomy & lumpectomy), 
removal of lymph nodes (axillary lymph node dissection and sentinel lymph biopsy), 
presence of positive nodes, radiation and chemotherapy (Mak et al., 2008; Paskett et al., 
2007), risk factors that can be managed or avoided are also identified, including obesity, 
weight gain after cancer treatment, minor upper extremity infections, injury or trauma to the 
affected side, overuse of the limb, and air travel (Johansson et al., 2002; Mak et al., 2008). 
Patient education is vital for implementing risk reduction behaviors targeting on such 
personal risk and triggering factors. In practice, many women treated for breast cancer have 
not received any information about lymphedema and risk reduction strategies (Fu et al., 
2010; Ridner, 2006).  
In a recent research on the effectiveness of lymphedema information provision among 136 
breast cancer survivors (Fu et al., 2008; Fu et al., 2010), the researchers revealed that 43% 
percent of the participants reported that they did not receive any lymphedema 
information. Significantly fewer women who received lymphedema information reported 
swelling, heaviness, impaired shoulder mobility, seroma formation, and breast swelling. 
Regarding the most distressing symptom of arm swelling, 41% of patients who did not 
receive information reported arm swelling, comparing to 19% of those who received 
information. In terms of important cardinal symptoms of lymphedema, patients who did 
not receive information also reported significantly more symptoms of heaviness (27%), 
impaired shoulder mobility (32%), seroma formation (34%), breast swelling (32%), 
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firmness/tightness (42%), numbness (39%), tenderness (54%), aching (36%), and stiffness 
(44%). In summary, patients who received lymphedema information reported 
significantly fewer symptoms than those who did not (t=3.03; p=0.00). With regard to risk 
reduction behaviors, patients who received information reported practicing significantly 
more risk reduction behaviors than those who did not (t=2.42, p=0.01). These behaviors 
included avoiding blood pressure, blood draws, and injections routinely done in the 
affected limb, wearing compression garments during air travel, treating minor injuries by 
washing and applying antibiotics, and most importantly, promoting lymph fluid 
drainage. In terms of cognitive outcome, patients who received information scored 
significantly higher in the knowledge test (t=0.49; p=0.00). The researchers developed a 
multiple regression model to assess the effects of provision of information on 
lymphedema related symptoms by taking into consideration of treatment-related risk 
factors. The results demonstrated that provision of information had significant reverse 
effect (B= -1.35; p<0.00) on lymphedema symptoms even taking into consideration of 
treatment-related risk factors. Together, provision of information and treatment-related 
risk factors account for 13% of variance (R2= 0.13). After controlling for confounding 
factors, patient education remains an important predictor of lymphedema outcome.  
Apparently, patient education is essential to promote risk reduction and early detection. 
In clinical practice, healthcare professionals could consider taking the initiative to provide 
adequate and accurate information and engage patients in supportive dialogues 
concerning lymphedema and risk reduction to improve patients’ cognitive, behavior, and 
symptom outcomes. Healthcare professionals should equip themselves with lymphedema 
knowledge, including risk identification, early detection, and risk reduction strategies. 
Pretreatment education should focus on potential risk for lymphedema, brief review of 
the lymphatic system and pathophysiology of lymphedema, signs and symptoms of 
lymphedema, and risk reduction behaviors to reduce the risk from personal and 
triggering factors. Patients should be educated about the need to seek for professional 
help immediately if they begin to experience feelings of heaviness or tightness in at‐risk 
limbs; or if they notice swelling in the affected area; or if the arm and/or at risk chest or 
truncal areas becomes hot or red. In the clinical settings, healthcare professionals could 
use the systematic assessment strategies to help patients to reduce the risk of 
lymphedema presented in Table 3.   
5.2 Early detection  
If undiagnosed or not treated effectively, lymphedema can progress into later stages of the 
condition resulting in a severe form of swelling known as elephantiasis (Figure 5). Early 
detection of lymphedema is believed to yield better patient outcomes to reduce the risk of 
the severe stage of lymphedema. To promote early detection, ongoing education should be 
conducted at each follow-up visit by reviewing the content of pretreatment education and 
encouraging the patient to report any signs and symptoms of lymphedema such as swelling, 
tightness, firmness, heaviness, aching, redness, rash, or increased temperature on the 
affected limb. As certain symptoms, such as tightness, and heaviness are associated with the 
onset of lymphedema (Armer et al., 2003; Cormier et al., 2009), it is important for healthcare 
providers to conduct a screening symptom assessment and refer breast cancer survivors 
with lymphedema to appropriate resources such as lymphedema therapy. (Table 3) 
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 copyright by Jane Armer. All rights reserved. 
Fig. 6. Example of severe lymphedema known as elephantiasis 
 
Risk Identification 
 Ask the patient about history of cancer treatment 
 Identify the affected or at-risk limb  
 
Risk Reduction 
 Recommend the patient use the unaffected side for blood pressure and blood work. 
 If the patient had a bilateral mastectomy, suggest use the lower extremities for blood 
work and blood pressure.  
Rationale: By using the unaffected side or lower extremities for blood draws and blood 
pressure, the patient will reduce the risk for infection, which lowers the risk of 
lymphedema. 
 
Early Detection 
 Use 3 questions to screen patients who might have developed lymphedema without 
awareness.  
? Have you noticed any swelling in the affected hand, arm, breast, or trunk area? 
? Have you experienced the feeling of heaviness, firmness, tightness in the affected side?  
? Have you experienced any new discomfort in the affected side? 
 Refer patient with early signs of symptoms to the certified lymphedema therapists. 
 Assess the patients for signs and symptoms of infections (redness, tenderness, and 
pain). Administer antibiotics as needed.  
Rationale:  
- Early symptoms of lymphedema include slight swelling, heaviness, tightness, or 
firmness. It is important for nurses to assess these symptoms at each patient encounter, 
since early intervention can sometimes reverse lymphedema symptoms. 
- It is important to assess signs and symptoms of infection (redness, tenderness, and 
pain). Infection, such as cellulitis, is the major predictor for lymphedema.  
Table 3. Systematic Assessment Strategies for Lymphedema Risk Reduction 
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To promote early intervention, it is imperative to implement screening and measurement for 
early detection of breast cancer-related lymphedema. In a prospective observational study 
on 196 women with newly diagnosed breast cancer over a five year period (Stout et al., 
2008), the women were measured using infra-red Perometry prior to their surgery and in 
three-month intervals following their surgery for up to one year. During that time, 
researchers were able to identify the development of subclinical lymphedema in 43 women 
(22%). The women with subclinical lymphedema (defined by the researchers as the limb 
volume change [LVC] of approximately 100 ml or a 3% LVC compared to the pre-op 
measure) were treated with an off-the- shelf sleeve and gauntlet, which was worn daily 
except during sleeping hours. Significant reduction in limb volume was observed that was 
similar to nearly the women’s pre-surgical baseline value in all patients over an average 
period of 4.4 weeks. It should be noted that pre‐treatment baseline measurement of limbs is 
essential, as this serves as the baseline data to which subsequent measurements can be 
compared. Healthcare professionals should use a cost-effective measuring method (such as 
circumferential arm measurement) and a time- and energy-saving measuring method (such 
as infra-red perometry) to monitor LVC in breast cancer survivors. Limb volume 
measurement should be conducted by the healthcare professionals who treat breast cancer 
and follow breast cancer survivors at each patient visit. In this way, patients with increased 
LV in the affected limb can be referred in a timely manner for further assessment and early 
intervention by specialists in lymphedema treatment. 
6. Self-management for breast cancer-related lymphedema 
Self-management for breast cancer-related lymphedema focuses on daily activities and 
strategies undertaken by breast cancer survivors to decrease the swelling, relieve symptoms, 
and prevent acute exacerbations and infections (Fu, 2005). As discussed previously, CDT 
requires patients to make a daily commitment by using external compression (sleeve, glove, 
wrap, bandage, or pump), performing remedial exercise, self-MLD and skin care (Davis, 
1998; Rockson, et al. 1998). Self-management is essential for the success of the maintenance 
phase of the complete decongestive therapy (CDT) (Fu, 2010). Successful self-management 
of lymphedema also requires breast cancer survivors to initiate and maintain behaviors 
reduce triggering factors that can lead to severe lymphedema (Fu, 2005).  
Limited research has been conducted on effective self-management of lymphedema. Very 
few exiting research are descriptive in nature yet the studies have delineated the difficulties 
and barriers that impede the effective self-management of lymphedema. A recent study 
revealed the major barriers to effective daily self-management include fatigue, lack of 
sufficient supporting system, insufficient financial resources, insufficient time, occupations 
involving manual laborious work, employers’ misunderstanding, unsupportive working 
environment, fear of losing job (or stigma, embarrassment or discrimination), irregular 
working schedules, lack of clear or detailed instructions for self-care, lack of experience of 
organizing or following a schedule, and lack of experience of establishing or maintaining a 
routine (Fu, 2010). Currently, no research has been targeting on the identified barriers to 
promote self-management.  
Breast cancer-related lymphedema is a chronic disease that, unlike other chronic illnesses 
such as arthritis or diabetes, receives little attention from healthcare professionals in clinical 
settings. To provide an emotional outlet for breast cancer survivors who may be concerned 
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about developing lymphedema, healthcare professionals should consider asking the 
survivors if anyone has talked to them about lymphedema risk reduction practices, and if 
they are concerned about possibly developing lymphedema. For those with lymphedema, 
healthcare professionals may wish to ask about any problems they are having with swelling, 
skin integrity, or other problems or concerns they want to discuss related to their 
lymphedema. These activities, if done in any clinical setting, would begin to address the 
feelings of abandonment by healthcare professionals verbalized by many breast cancer 
survivors with lymphedema (Carter, 1997). Management of psychological distress and 
fatigue associated with lymphedema and self-management may require supportive services 
from healthcare professionals such as psychologists or conditioning experts (Fu, 2005; 
Ridner, 2005). 
Similar to the self-management for other chronic illnesses, healthcare professionals have a 
significant role in ensuring effective self-management of lymphedema by motivating breast 
cancer survivors. Some cognitive, psychological, and social strategies can help breast cancer 
survivors to promote and maintain self-management behaviors (Fu, 2004). Cognitive 
strategies refer to breast cancer survivors’ ability to understand the need for change of 
behaviors to implement daily self-management activities and ability to identify and 
overcome barriers in carrying out such activities. Patient education is the optimal way to 
enhance breast cancer survivors’ knowledge and provide relevant resources.  
Psychological strategies include those that help breast cancer survivors set goals for their 
lymphedema management and motivate them to continue their daily management 
activities. Fu (2005) identifies four major intentions undertaken by breast cancer survivors to 
promote effective daily lymphedema management: keeping in mind the consequences, 
preventing lymphedema from getting worse, getting ready to live with lymphedema, and 
integrating the care of lymphedema into daily life. The four intentions reveal in detail the 
way in which breast cancer survivors structure their lives to manage lymphedema daily. 
Healthcare professionals are in the best position to identify breast cancer survivors’ 
individual needs by assessing the presence or absence of the intentions. In another recent 
study (Fu, 2010), the researcher described how breast cancer survivors actively and 
creatively structured their lives to make lymphedema self-management feasible by making 
conscious decisions about new-fangled limitations, making daily care feasible, and 
incorporating lymphedema care into daily routine. The study also identified effective and 
ineffective strategies and barriers to fulfill the intentions of self management (Table 4). 
Research is needed to develop interventions to test the identified effective strategies for self-
management of lymphedema.    
Social strategies focus on providing resources or support groups to externally enhance 
breast cancer survivors’ motivation to continue self-management to maintain LV and deal 
with physical symptoms as well as psychological distress and social anxiety. Internal and 
external resources, such as programs about lymphedema treatment and reliable internet 
websites, should be given to breast cancer survivors. Providing social support helps mitigate 
breast cancer survivors’ sense of being singled-out, a perspective that was vividly described 
by a breast cancer survivors with five years of lymphedema, “You feel that you are on this 
little island by yourself and just struggling because there is no one else around who knows 
what lymphedema is” (Fu, 2003, p. 188). Support group in which women can feel free to 
share their success stories about lymphedema management and the ways of overcoming 
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Making Self Management Feasible 
Intentions Effective Strategies Barriers to the strategy 
Ineffective 
Strategies 
Making Conscious 
Decisions about 
New-fangled 
Limitations 
 Giving up 
 Letting go 
 Asking for help 
 Paying for help 
 Using the unaffected limb 
 Lack of sufficient 
supporting system of 
family, friends, and 
coworkers 
 Unsupportive working 
environment 
 Employers’ 
misunderstanding 
 Insufficient financial 
resources 
 Occupations involving 
manual laborious work 
 Impatience 
 Ignoring 
 Forgetting 
 Neglecting 
Making daily Care 
Feasible 
 Wearing daytime 
compressive garments as 
much as possible 
 Using Easy Slide or other 
device to help putting on 
the compression sleeve 
 Wrapping the affected 
arm during nighttime 
 Using rubber gloves to 
protect the compression 
gloves from getting dirty 
 Performing exercise and 
massage if time and 
physical stamina allow 
 Getting an easy access to 
the things needed for 
lymphedema care 
 Spacing out the 
household chores 
 Having  someone help 
 Wearing protective 
gloves for dish washing, 
cleaning, and gardening 
 Using food processor to 
cut food 
 Lack of clear or detailed 
instructions 
 Insufficient time 
 Insufficient financial 
resources 
 Insufficient qualified 
therapists 
 Fatigue 
 Fear of losing  job, stigma, 
embarrassment or 
discrimination 
 Occupations involving 
manual laborious work 
 Employers’ 
misunderstanding 
 Unsupportive working 
environment 
 Lack of sufficient 
supporting system 
 Trying to do all 
that you were 
told 
Incorporating 
Lymphedema Care 
into Daily Routine 
 Establishing and 
sustaining a daily routine 
 Foreseeing the changes in 
life 
 Readjusting to the 
established routine 
 Lack of experience of 
organizing or following a 
schedule 
 Lack of experience of 
establishing or maintaining 
a routine 
 Insufficient time 
 Irregular working schedules 
 Fatigue 
 Being a good wife and 
loving mother 
 Following an 
irregular 
schedule 
Table 4. Intentions, Effective strategies, Barriers and Ineffective Strategies (Adapted from: 
Fu, M.R. (2010). Cancer Survivors’ views of lymphoedema management. Journal of 
Lymphoedema, 5(2), 39-48.) 
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barriers is an effective way to provide social support (Fu, 2005). Well-designed support 
groups can also enhance skills for effective lymphedema management through group 
practice of certain skills such as easier ways of putting on a compression garment, applying 
bandage or wraps, and performing self-MLD. Group practice allows the opportunity not 
only for building a community to further promote breast cancer survivors’ sense of 
belongingness, but also for transforming routine lymphedema management activities into 
fun activities that may elicit interest and enjoyment to sustain the women’s motivation. The 
lifetime commitment to manage lymphedema requires time and effort by both breast cancer 
survivors and healthcare professionals to insure that quality life is not profoundly impacted.  
7. Strategies for personal and family-level care 
7.1 Individual-level psychosocial impacts 
It has been well documented that psychological health can be impacted by changes in 
physical appearance and limitations created by lymphedema (e.g., Petrek et al., 2001; Radina 
& Armer, 2001, 2004; Thomas-MacLean et al., 2005). This includes both mental health 
concerns and the ways in which patients cope with the physical limitations brought on my 
breast cancer-related lymphedema in their daily lives. 
7.1.1 Mental health concerns 
In addition to the physical limitations of breast cancer-related lymphedema, patients are 
also subject to potential psychosocial problems including depression, anxiety, poor 
adjustment to illness, and low self esteem (Maunsell, Brisson, & Deschenes, 1993; Thomas-
MacLean et al., 2005). Chachaj and collegues (2010) found that there were several factors 
that contributed to patients’ experiences of negative psychosocial outcomes. These included 
“pain in the upper limb (mainly shoulder and arm), pain in operated breast, difficulties with 
arm movement, localization of lymphedema within the hand or in operated breast, a history 
of dermatolymphangitis and of receiving chemotherapy”(p. Vassard and colleagues (2010) 
explored the psychosocial outcomes of patients engaged in post-breast cancer surgery 
rehabilitation. They found that compared with patients who did not develop lymphedema, 
those with lymphedema reported a greater impact on their psychological well-being. 
Specifically, patients with breast cancer-related lymphedema were more likely to report 
lower overall quality of life and perceiving themselves to be in poorer health. These findings 
are similar to those reported by Heiney and colleagues (2007) who found that both physical 
and social aspects of quality of life were impacted by breast cancer-related lymphedema. 
Researchers have also found that the degree to which patients experience negative impacts 
on their mental health and quality of life is correlated with the severity of the lymphedema 
symptoms and the degree to which these symptoms are viewed as distressful (Erickson et 
al., 2001; Kornblith, Herndon, Weiss, Zhang, Zuckerman, Rosenberg et al., 2003). Similarly, 
Ridner (2005) found that patients with breast cancer-related lymphedema reported higher 
levels of emotional distress and reduced body confidence then those without lymphedema. 
Certainly this finding of reduced body confidence has implications for patients’ self-esteem 
as well as sexual intimacy. With regard to addressing psychosocial problems in this 
population, Hamilton, Miedema, MacIntyre, & Easley, 2011) investigated the use of a 
positive self-talk intervention. Their findings suggest that such interventions may have a 
positive impact on patients’ coping skills. They argue that further investigations are needed 
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to determine appropriate psychological interventions that positively impact such mental 
health concerns as anxiety and depression among patients with breast cancer-related 
lymphedema.  
7.1.2 Coping with physical limitations in daily life 
Lymphedema can impose limitations on women’s lives in terms of their ability to participate 
in normal, daily activities (Radina & Armer, 2001; Ridner, 2002). Radina (2009) found that 
women with breast cancer-related lymphedema experienced a heightened sense of 
awareness and caution concerning their physical activities, as well as a sense of frustration 
with the limitations they faced as a result of breast cancer-related lymphedema. At the same 
time, these women also must engage in time consuming self-care, as described above, in 
order to reduce and control the swelling associated with lymphedema (e.g., manual lymph 
draining, CDT). Not only are some of these treatments restricting in terms of range of 
motion, but they also require the patient to set aside time during the day to perform them 
and to potentially ask others (i.e., family members) for help. The patient must also avoid 
getting any wrappings wet and therefore must remove the wrapping and rewrap the arm 
for bathing or other water activities (e.g., swimming, washing dishes). Lastly, because the 
compression sleeve is so expensive and must be washed by hand everyday, the patient must 
be careful not to stain or otherwise damage the sleeve (Casley-Smith, 1992).  
7.2 Family/interpersonal relationship-level psychosocial impacts 
Given the increasing large population of women living as breast cancer survivors and the 
understanding that breast cancer impacts the entire family, not just the patient/survivor 
(Baider, Cooper, & Kaplan De-Nour, 2000; Veach, Nicholas, & Barton, 2002), a growing 
number of families may be facing the need to navigate survivorship as well. At the same 
time, given that as many as 40% of women who have gone through breast cancer treatment 
may develop breast-cancer related lymphedema, there is also a growing number of families 
who are not only needing to cope with cancer survivorship in general but also coping daily 
with the chronic condition of lymphedema.  
The study of breast cancer survivorship in general has largely centered on the experiences of 
breast cancer patients and has failed to sufficiently consider the impact that breast cancer 
diagnosis and treatment can have on family members and family life. The majority of work 
that considers family members is focused on breast cancer patients’ relationships with 
husbands and young children (e.g., Northouse, Laten, & Reddy, 1995; Radina, 2009; Radina 
& Armer, 2001; 2004, Radina, Watson, & Faubert, 2009; Rees & Bath, 2000) and the 
individual quality of life of patients and their family members in the context of breast cancer 
(e.g., Kim & Given, 2008; Northouse et al., 2002). Only recently have researchers focused 
attention on how family functioning and adaptation can influence the lives of breast cancer 
patients and survivors (e.g., Mallinger, Griggs, & Shields, 2006; Radina, 2009; Radina & 
Armer, 2001; 2004; Radina et al., 2009). The evolution of empirically based understanding of 
how cancer in general impacts the family continues to evolve. The limited research that 
explores family dynamics in the context of breast cancer focuses on issues such as 
participation in treatment decision making (Lacey, 2002; Raveis & Pretter, 2004), family 
communication patterns both prior to and after the breast cancer diagnosis (Forest, Plumb, 
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Ziebland, & Stein, 2009; Mallinger et al., 2006), and the family’s role as either a supportive or 
distressing unit (Alfano & Roland, 2006; Spencer et al., 1999). Here we review the research 
that has been conducted that investigates the specific ways in which breast cancer patients 
with lymphedema experience their family and interpersonal lives with regard to family 
work, family play, and sexual intimacy with significant romantic others. We conclude by 
exploring a theory of health-related family quality of life and how it might be applied to 
families coping with breast cancer-related lymphedema.  
7.2.1 Family work and family play 
The daily lives and rhythms of families include both getting the work of the family 
completed (i.e., housework) and the maintenance of family relationships (i.e., spending 
quality time together). Researchers have shown that both aspects of family functioning 
can be impacted by the onset and continued care required of breast cancer-related 
lymphedema (Radina, 2009; Radina & Armer 2001; 2004). That is, the physical limitations 
and psychosocial difficulties experienced by women with lymphedema frequently require 
the individual and her family members to renegotiate family roles and modify how they 
function as a unit (Radina & Armer, 2001; 2004). With regard to family work, this may 
include a redistribution of household responsibilities (i.e., asking an adult son to run the 
vacuum or employing a maid service to do the heavy cleaning) or the modification of how 
and if such responsibilities are undertaken (i.e., lowering standards of household 
cleanliness, learning to use the other arm to sweep the kitchen floor) (Radina & Armer, 
2001). Women at-risk for developing breast cancer-related lymphedema have been shown 
to struggle with balancing the needs of others (e.g., family members) with their own 
needs for self-care that are aimed at reducing their risk of developing or exacerbating 
breast cancer-related lymphedema (Radina, Armer, & Stewart, under review). Gilligan 
and others (e.g., Jack, 1991; Ruddick, 1989) have argued that women are socialized within 
family and community life to embrace this concept of self-sacrifice in the service of others. 
Caring for others, and doing so in an unselfish way or at the expense of one’s own needs, 
is the currency that women are socialized to deal with in order to create and maintain 
relationships with others (Jack, 1991). The role women often assume in family life requires 
some degree of self-sacrifice in order to manage the household and take care of family 
members (Mederer, 1993), including paid work outside the home. In this sense, what gets 
put on hold are activities like personal care, medication, exercise, or other activities that 
are largely for the benefit of the woman alone and not explicitly benefiting the family as a 
whole or individual family members. Radina and colleagues (under review) found that 
women at-risk for developing breast cancer-related lymphedema struggled with making 
their self-care a priority despite being enrolled in an intervention study aimed at teaching 
them techniques for self-care to reduce their risk of developing breast cancer-related 
lymphedema. Often the major barrier to self-care was the pull they felt to put others’ 
needs first. Consistent with Ridner, Dietrich, and Kidd (2011) of women diagnosed with 
lymphedema, Radina et al. (under review) found that these women at-risk for developing 
lymphedema struggled with finding the time in their daily lives to engage in self-care. 
Radina and colleagues’ findings highlight the important role that social contexts (e.g., 
family life, gendered expectations) can play as a factor in personal care for breast cancer 
survivors. 
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Radina (2009) found that for some women with breast cancer-related lymphedema, lifestyle 
modifications extend beyond daily activities such as dressing, bathing, cooking, and 
housekeeping into the realm of leisure. When it comes to leisure activities, wives and 
mothers who are often responsible for family management, are likely to be the ones creating 
time and space for other family members’ independent leisure activities (e.g., backing 
cupcakes for her son’s football team party, driving children to music lessons). Because of 
these other responsibilities, women’s independent leisure is often sacrificed so that they can 
accomplish these other tasks for their families (Henderson, Bialeschki, Shaw, & Freysinger, 
1999).  
For women, their own participation in leisure activities in general, whether engaged in 
individually or with their families, may act as a buffer against stressful life events such as 
breast cancer and breast cancer-related lymphedema (Pondé & Santana, 2000). Thus, the 
continued participation of women with lymphedema in leisure activities appears valuable 
for sustaining their quality of life after breast cancer treatment. At the same time, family 
leisure is important for understanding family functioning (Zabriski & McCormick, 2001), 
particularly in the context of chronic health conditions and health-related disabilities (Jo, 
Kosciulek, Huh, & Holecek, 2004). Radina (2009) found that breast cancer-related 
lymphedema can create serious limitations that can impact both family functioning and 
participation in leisure.  
Family interaction in the context of leisure enhances the family’s ability to remain stable 
(Orthner & Mancini, 1990). In fact, researchers have demonstrated that there is a positive 
relationship between family leisure engagement, family satisfaction, and family quality of 
life (Zabriskie & McCormick, 2003). The Core and Balance Model of Family Leisure 
Functioning (Zabriskie, 2000; Zabriskie & McCormick, 2001) suggests that family 
adaptability (i.e., the family’s ability to be flexible and change), cohesion (i.e., closeness, 
emotional bonding), and communication are facilitated through family members’ joint 
engagement in family-based leisure activities (Zabriskie & McCormick, 2001). These can 
include both core and balance leisure activities. Core leisure activities are “common 
everyday, low-cost, relatively accessible, and often home-based activities that families do 
frequently” (Zabriskie & McCormick, 2003, p. 168) including such activities as playing a 
game, e-mailing or instant messaging with family members, and making/eating dinner 
together (Zabriskie & McCormick, 2001). Core leisure activities tend to be associated with 
the maintenance of family cohesion and thus families who perceived themselves as having 
high levels of emotional closeness report engaging in more core leisure activities (Zabriskie, 
McCormick, & Austin, 2001). Balance leisure activities are “less common, less frequent, more 
out of the ordinary, and usually not home based thus providing novel experiences” 
(Zabriskie & McCormick, 2003, p. 168) including such activities as family travel, family 
reunions, and special family events (Zabriskie & McCormick, 2001). Balance activities tend 
to be associated with maintaining family adaptability (Zabriskie et al., 2001). According to 
the Core and Balance Model, in order to have healthier family functioning that results from 
increased levels of family communication, families should participate in both core and 
balance activities that enhance both family cohesion and adaptability (Zabriskie & 
McCormick, 2003).  
The role that family leisure plays generally also applies to families in which there is a 
chronically ill or disabled member (i.e., lymphedema). For such families participating in 
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shared leisure time is associated with enhanced family communication and stability (Guerin 
& Dattilo, 2001). For individuals with disabilities, the benefits of leisure activities (e.g., 
increases in self-confidence, social networks, and one’s sense of accomplishment and 
satisfaction) have been well-established (Jo et al., 2004; Lloyd, King, Lampe, & McDougall, 
2001). Despite this relationship, families with a disabled member are less likely to participate 
in balance leisure activities (38%) compared to families without a member with a disability 
(52%; Jo et al., 2004).  
Radina (2009) found that women with breast cancer-related lymphedema approached their 
participation in family leisure activities in two ways. The first involved continued 
participation in family leisure activities but with extra care (e.g., purchasing light weight 
hiking equipment) or being creative about how they participated (e.g., becoming the scout 
troop treasurer rather than accompanying children on back packing trips). The second 
strategy involved withdrawing from family activities that according to the Core and Balance 
Model (Zabriskie et al., 2001) could jeopardize overall levels of family functioning by 
eliminating opportunities for building or improving family adaptability, cohesion, or 
communication.  
7.2.2 Sexuality and intimacy 
Sexuality can be examined as an interaction of biological, psychological, and social domains 
of life (Lindau, Laumann, Levinson, & Waite, 2003; National Institute on Aging, 2005). How 
individuals feel about themselves as sexual beings is impacted by a combination of all three 
of these areas. As women with breast cancer-related lymphedema have already faced breast 
cancer, their feelings about sexuality and intimacy are intertwined with their breast cancer 
and lymphedema experiences. Thus, it may not be possible to completely distinguish 
between body image issues, feelings of sexuality, and the impact on sexual relationships 
brought about by breast cancer and those resulting from lymphedema.  
Researchers have explored the impact of breast cancer on sexuality and sexual relationships 
(e.g., Henson, 2002). This work has included investigations into the impact of breast cancer 
and its treatment on hormones and sexual functioning, attitudes of a romantic partner, the 
impact of fatigue brought about by treatment on sexual relationships, and how an altered 
body image resulting from (breast) cancer can impact one’s sexuality and sexual 
relationships (Gould, Grassau, Manthorne, Gray, & Fitch, 2006). Research also have focused 
on how there tends to be a lack of information on how breast cancer and its treatment can 
impact sexuality that is provided to breast cancer patient and their partners (Gould et al., 
2006; Henson, 2002). 
With breast cancer-related lymphedema, women may experience changes in their 
appearance as well as pain and physical limitations due to swelling (Passik & McDonald, 
1998). As sexuality is connected to a woman’s feelings about herself and her body, not only 
the experience of breast cancer, but also the development of lymphedema can have a serious 
impact on her views of herself as sexual and her willingness to be physical with a partner. 
Having survived breast cancer to now have to contend with breast cancer-related 
lymphedema can be seen “as a secondary blow to their physical and emotional well-being,” 
which includes their intimate relationships with others (Passik and McDonald, 1998, p. 
2818). Research (e.g., Koch et al., 2005; Radina, Watson, & Faubert, 2009; Wiederman & 
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Hurst, 1997) has highlighted the negative ways in which women with breast-cancer related 
lymphedema feel about their bodies and how these feeling can take away from their desire 
to engage in sexual activity with a partner. Radina et al (2009) and Gould et al. (2006) found 
that the disfiguring aspects of breast cancer as well as breast cancer-related lymphedema 
made women feel unattractive and self-conscious about their bodies. Radina et al (2009) also 
found that women with breast-cancer related lymphedema expressed feeling that current or 
future sexual partners might not find them sexy because of the lymphedema and/or the 
compression garments that they need to be wear to treat their conditions.  
There are numerous studies that explore the connection of sexual satisfaction, self or body 
image, and physical disability (e.g., Kedde & van Berlo, 2006; Taleporos, Dip, & McCabe, 2002; 
Galvin, 2005). Lymphedema can be not only be a condition with disfiguring effects but also 
debilitating ones. Galvin (2005) studied narratives of disabled people with a diverse range of 
disability and impairment. Based on this research, the term “disabled identity” emerged to 
reflect a self-perception that is affected by appearance, sexuality, and the negative attitudes of 
others. Shame and fear of rejection were related to reactions from others for those whose 
impairment was evident or visible. Feelings of loss of attractiveness, negative reactions of 
others, and internalized societal messages about the asexuality of disabled people contributed 
to feelings of loss of sexuality in many of the narratives (Galvin, 2005). Although not a 
“disability,” because of the disfiguring and disabling aspects of the condition of lymphedema, 
the “disabled identity,” which is impacted by an internalization of how others view this 
condition, can negatively impact sexuality and one’s desire to be sexual with others.  
7.2.3 Family quality of life 
Radina and Armer (2004) explored outcomes for women with breast cancer-related 
lymphedema within the context of their families using the Resiliency Model of Family 
Stress, Adjustment, and Adaptation (M. A. McCubbin & H. I. McCubbin, 1996). They found 
instances where participants described themselves and their families as either adjusting (i.e., 
making small changes in family patterns of functioning in order to cope with lymphedema), 
adapting (i.e., making major changes in family patterns of functioning in order to cope with 
lymphedema), or living in crisis. Specifically, those families who were resilient had shared 
perception of the limitations brought on by lymphedema as being manageable and 
something that could be incorporated into patterns of daily living. At the same time, the 
more resilient families pulled together as a family to make necessary changes (e.g., the entire 
family focusing on the lymphedema and supporting the patient, the patient or her spouse 
changing jobs, using humor and inside jokes). The ingenuity and perseverance 
demonstrated by resilient families suggest that the families of women with breast cancer-
related lymphedema can be resilient in coping with lymphedema. 
One way to think about family life in the context of breast cancer-related lymphedema is to 
consider the concept of health-related family quality of life. Health-related family quality of 
life refers to a state of being for families in the context of one or more family members’ 
illnesses as well as the processes that families use to cope. Below I provide an overview of a 
theory of Health-Related Family Quality of Life whose purpose is to provide a model of 
understanding what family quality of life is within the specific context of breast cancer and, 
by extension, breast cancer-related lymphedema. Below the assumptions, concepts, and 
propositions of this theory of Health-Related Family Quality of Life are presented. 
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The first assumption is that families are made up of multiple actors who interact based on 
established patterns of functioning that are governed by rules that can be both explicit and 
implicit (Bigner, 1998). Second, new or revised patterns of functioning can result when a 
stressor (e.g., breast cancer) is encountered by the family (M. A. McCubbin & H. I., 
McCubbin, 1991; 1996; Olson, Lavee, & McCubbin, 1988). Third, the introduction of that 
stressor to the family allows for established patterns of functioning to become apparent 
when they otherwise might not be (Ingoldsby, Smith, & Miller, 2004; Molassiotis, 1997). 
Fourth, quality of family life is subjective and situation-dependent (McCabe et al., 2008). 
As is detailed in Figure 5, the theory of Health-Related Family Quality of Life is made up of 
three overarching concepts: emotional closeness, family self-efficacy, and family 
functioning. Emotional closeness includes feelings of psychological or affectional closeness 
toward and/or between family members as well as such feelings toward the family as a unit 
(Bengtson, 1991; Poston et al., 2003). At the same time, the concept of emotional closeness 
also includes family communication as a way of facilitating and demonstrating closeness 
(Bigner, 1998; M. A. McCubbin & H. I., McCubbin, 1991; 1996; Poston et al., 2003). Family 
communication is made up of family members’ feelings regarding the quality, quantity, 
frequency, and content of this communication (Bengston, 1991). Lastly, the concept of 
emotional closeness also includes social support-both among family members and for the 
family as a unit from those outside the family. Social support can also be considered a 
resource that the family uses in managing the quality of their family life (Hill, 1949; 
Patterson, 2002; Poston et al., 2003). Family Self-Efficacy refers to the families meaning-
making about themselves as a unit and the illness (i.e., sense of coherence), in this case 
breast cancer. Hill (1949) and others (e.g., Anderson, 1993; Caplan, 1987; McCabe et al., 2008) 
point to the importance of appraisal of stressors as essential to understanding how the 
stressor will be handled. That is, if a family considers the stressor to be catastrophic, this 
may have a negative influence on family quality of life in that it may be seen as irrevocable 
damaged. As part of this meaning-making, family self-efficacy includes family members’ 
sense of both family strengths (Smith-Bird & Turnbull, 2005) and their ability to cope with 
challenges (i.e., possibly based on the family’s history of how they face challenges and their 
success with overcoming them; Hill, 1949; M. A. McCubbin & H. I., McCubbin, 1991; 1996; 
Mellon & Northouse, 2001; Patterson, 2002). Lastly, Family Functioning consists of family 
members’ roles and responsibilities (e.g., family care, daily activities, getting help) as well as 
their satisfaction with how well the family meets individual and family unit needs (Bigner, 
1998; Ingoldsby et al., 2004; Park et al., 2003; Rettig & Leichtentritt, 1999). 
The theory of Health-Related Family Quality of Life offers three propositions about how 
health-related family quality of life functions. First, the theory of Health-Related Family 
Quality of Life is based on family members’ perceptions of emotional closeness, family 
efficacy, and satisfaction with needs being met. Second, changes in family quality of life are 
based on perceptions of changes in emotional closeness, family self-efficacy, and patterns of 
functioning. Third, emotional closeness and family self-efficacy are considered resources 
that families utilize when faced with a stressor.  
The application of the theory of Health-Related Family Quality of Life sheds light on the 
varying factors that can contribute to how a family reacts to and copes with breast cancer-
related lymphedema. For some families these factors may already be working well meaning 
that they will be predisposed to maintain a positive health-related quality of life in the 
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context of breast cancer-related lymphedema. Others, however, may need coaching from 
trained professionals in order to enhance or improve their health-related quality of life. The 
professionals need not be family counselors, family life educators, or social works alone. 
Others, including health care professionals, should be aware of the impact breast cancer-
related lymphedema can have on family quality of life so that they may also help both 
patients and their family members thrive. 
 
Fig. 7. Theory of Health-Related Family Quality of Life 
8. Conclusion 
Up to 40% of breast cancer patients are likely to develop breast cancer-related lymphedema. 
Thus, patients and their family members must learned to not only prepare for but cope with 
this often disabling chronic condition. Thus, the focus of this chapter was on patient (and 
family member/caregiver) education regarding strategies for early detection, risk reduction, 
and management/self-care and the individual and family level psychosocial impacts of 
coping with breast cancer-related lymphedema. The topics covered in this chapter were 
chosen with the intention of informing readers (e.g., physicians, nursing, social workers, 
family therapists, family life educators, and others who work with patients and their 
families) about the needs of patients and their family members and provide strategies to 
meet the needs of patients and families. In this way,  wide ranging support for patients and 
their family members would be encouraged and implemented throughout the trajectory of 
patient care.   
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